drugset / Trial / NCT03485625

Adjuncts to IVRA, a Comparison Between Ketorolac and Paracetamol

NCT03485625

Phase 3 Completed 60 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study was planned to compare the effect of ketorolac 20 mg to 300 mg of paracetamol when added to lidocaine 3 mg/kg for Intravenous regional anaesthesia.

Timeline

Start
2018-03-21
Primary completion
2019-04-28
Completion
2019-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 300 mg Intravenous
Subject Ketorolac Other / unclassified 20 mg Intravenous
Background Lidocaine Other / unclassified 3 mg/kg Intravenous

Indications

No indication recorded.